Published in J Biol Chem on December 27, 1996
Ferritin and the response to oxidative stress. Biochem J (2001) 1.88
Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol (2000) 1.58
Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice. J Neurosci (2008) 1.30
Noninvasive monitoring of embryonic stem cells in vivo with MRI transgene reporter. Tissue Eng Part C Methods (2009) 1.19
Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene. J Neurochem (2009) 1.14
The catalytic center of ferritin regulates iron storage via Fe(II)-Fe(III) displacement. Nat Chem Biol (2012) 0.99
Catalysis of iron core formation in Pyrococcus furiosus ferritin. J Biol Inorg Chem (2009) 0.96
Chelators in the treatment of iron accumulation in Parkinson's disease. Int J Cell Biol (2012) 0.95
Abnormal iron metabolism in fibroblasts from a patient with the neurodegenerative disease hereditary ferritinopathy. Mol Neurodegener (2010) 0.87
Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism. Am J Pathol (1998) 0.87
Transient overexpression of human H- and L-ferritin chains in COS cells. Biochem J (1998) 0.85
Nuclear cytoplasmic trafficking of proteins is a major response of human fibroblasts to oxidative stress. J Proteome Res (2014) 0.76
Sequence analysis of dolphin ferritin H and L subunits and possible iron-dependent translational control of dolphin ferritin gene. Acta Vet Scand (2008) 0.75
"Pumping iron"-how macrophages handle iron at the systemic, microenvironmental, and cellular levels. Pflugers Arch (2017) 0.75
A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science (1985) 4.98
Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci (2008) 4.24
The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J Biol Chem (1988) 2.15
Hormonal risk factors in testicular cancer. A case-control study. Am J Epidemiol (1986) 1.97
Development of the human gastrointestinal tract. A review. Gastroenterology (1976) 1.93
Ferritin and the response to oxidative stress. Biochem J (2001) 1.88
A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol (1996) 1.69
Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. J Clin Oncol (1985) 1.65
Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem (1995) 1.61
Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci U S A (1990) 1.59
Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol (2000) 1.58
Response of hormone refractory prostate cancer to lycopene. J Urol (2001) 1.40
Lipoprotein of gram-negative bacteria is essential for growth and division. Nature (1976) 1.39
Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc Natl Acad Sci U S A (1991) 1.36
Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J Clin Invest (1993) 1.36
Tumor necrosis factor inhibits human myogenesis in vitro. Mol Cell Biol (1988) 1.35
Bladder cancer, 1996. CA Cancer J Clin (1996) 1.32
Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy. Ann Intern Med (1983) 1.19
The biology and treatment of superficial bladder cancer. J Clin Oncol (1984) 1.18
Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy. Cancer Res (1986) 1.17
Recombinant ferritin: modulation of subunit stoichiometry in bacterial expression systems. Protein Eng (1997) 1.13
Interleukin 1 induces ferritin heavy chain in human muscle cells. Biochem Biophys Res Commun (1990) 1.12
Brain metastases from transitional cell carcinoma of the bladder. J Urol (1988) 1.10
FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcriptional repression. Mol Cell Biol (1995) 1.08
Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta. J Cell Biol (1989) 1.07
A comparison of the quality of participation of community affiliates and that of universities in the Northern California Oncology Group. J Clin Oncol (1983) 1.07
Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain. J Biol Chem (1991) 1.06
Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans. Cancer Res (1993) 1.02
Weekly doxorubicin in endocrine-refractory carcinoma of the prostate. J Clin Oncol (1983) 0.99
p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator. Carcinogenesis (2001) 0.98
Evidence for two mechanisms by which tumor necrosis factor kills cells. J Biol Chem (1989) 0.98
Serum markers in germ cell neoplasms. Hematol Oncol Clin North Am (1991) 0.95
Tumor cell cytotoxicity of a novel metal chelator. Blood (1998) 0.95
Iron and ferritin in inflammation and cancer. Adv Inorg Biochem (1994) 0.95
Preferential repression of the H subunit of ferritin by adenovirus E1A in NIH-3T3 mouse fibroblasts. J Biol Chem (1993) 0.94
Role of protein phosphorylation in TNF-induced apoptosis: phosphatase inhibitors synergize with TNF to activate DNA fragmentation in normal as well as TNF-resistant U937 variants. J Cell Biochem (1993) 0.94
Extralymphatic Hodgkin's disease. Prognosis and response to therapy. Am J Med (1981) 0.93
Patterns of failure in small cell carcinoma of the lung. Cancer (1982) 0.92
Human H-kininogen is a ferritin-binding protein. J Biol Chem (1998) 0.92
Adenovirus E1A blocks oxidant-dependent ferritin induction and sensitizes cells to pro-oxidant cytotoxicity. FEBS Lett (1999) 0.91
Transcriptional regulation of the mouse ferritin H gene. Involvement of p300/CBP adaptor proteins in FER-1 enhancer activity. J Biol Chem (1999) 0.91
Activation of the ferritin H enhancer, FER-1, by the cooperative action of members of the AP1 and Sp1 transcription factor families. J Biol Chem (1998) 0.91
The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study. J Urol (1985) 0.88
Cisplatin, methotrexate and vinblastine plus surgical restaging for patients with advanced transitional cell carcinoma of the urothelium. J Urol (1993) 0.88
The chemotherapy of prostatic adenocarcinoma. Ann Intern Med (1980) 0.87
Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy. J Urol (1992) 0.86
Superficial bladder cancer. Risk of recurrence and potential role for interferon therapy. Cancer (1987) 0.86
Efficient scheduling of cystoscopies in monitoring for recurrent bladder cancer. Med Decis Making (1989) 0.86
Regulation of NF-kappaB and HIV-1 LTR activity in mouse L cells by ultraviolet radiation: LTR trans-activation in a nonirradiated genome in heterokaryons. Exp Cell Res (1997) 0.86
Augmentation by IL-1 alpha of tumor necrosis factor-alpha cytotoxicity in cells transfected with adenovirus E1A. J Immunol (1993) 0.86
Tumor necrosis factor-induced c-myc expression in the absence of mitogenesis is associated with inhibition of adipocyte differentiation. Proc Natl Acad Sci U S A (1993) 0.85
Primary osteogenic sarcoma of the bladder. Case report and review of the literature. Cancer (1986) 0.84
Possible risk of invasive pulmonary aspergillosis with marijuana use during chemotherapy for small cell lung cancer. Drug Intell Clin Pharm (1986) 0.84
Radio frequency ablation of lung metastases from renal cell carcinoma. J Urol (2001) 0.84
Gynecomastia in testicular cancer patients. Prognostic and therapeutic implications. Cancer (1985) 0.84
The core control system of intracellular iron homeostasis: a mathematical model. J Theor Biol (2012) 0.84
Adjuvant intravesicular pharmacotherapy for superficial bladder cancer. J Natl Cancer Inst (1991) 0.83
Murine ferritin heavy chain: isolation and characterization of a functional gene. Gene (1990) 0.83
The chemotherapy of bladder carcinoma: systemic therapy. Recent Results Cancer Res (1983) 0.83
Prognostic significance of a decline in serum human chorionic gonadotropin levels after initial chemotherapy for advanced germ-cell carcinoma. Ann Intern Med (1984) 0.82
Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion. J Urol (1991) 0.82
A randomized study of doxorubicin versus doxorubicin plus cisplatin in endocrine-unresponsive metastatic prostatic carcinoma. Cancer (1985) 0.81
Superficial bladder cancer: the primacy of grade in the development of invasive disease. J Clin Oncol (1987) 0.80
Evaluation of mRNA levels by the polymerase chain reaction in small cardiac tissue samples. J Mol Cell Cardiol (1991) 0.80
Hormonal control of adipocyte differentiation and adipocyte gene expression. Recent Prog Horm Res (1988) 0.80
Novel cytotoxic chelators that bind iron(II) selectively over zinc(II) under aqueous aerobic conditions. Biochem Soc Trans (2002) 0.80
Development of intestinal adenyl cyclase and its response to cholera enterotoxin. J Clin Invest (1973) 0.80
Response criteria in urologic malignancies. Recent Results Cancer Res (1983) 0.80
Endocrine therapy of prostate cancer. Cancer Treat Res (1998) 0.79
Selective inhibition of muscle gene expression by oxidative stress in cardiac cells. J Mol Cell Cardiol (1998) 0.79
Recent advances in the treatment of prostate cancer. Ann Oncol (1999) 0.79
The role of iron in the cytotoxicity of tumor necrosis factor. Lymphokine Cytokine Res (1993) 0.79
Heat localization for targeted tumor treatment with nanoscale near-infrared radiation absorbers. Phys Med Biol (2012) 0.78
Effect of verapamil on doxorubicin cardiotoxicity: altered muscle gene expression in cultured neonatal rat cardiomyocytes. Cancer Res (1993) 0.78
Chemotherapy of advanced transitional cell carcinoma of the uroepithelium. Cancer Chemother Pharmacol (1983) 0.78
Therapeutic approaches including interferon to carcinoma in situ of the bladder. Cancer Treat Rev (1985) 0.78
Superficial carcinoma of the bladder: natural history and the role of interferons. Semin Oncol (1986) 0.77
The extent of surgery after chemotherapy for advanced germ cell tumors. J Urol (1984) 0.77
Hormonal therapy for prostate cancer. N Engl J Med (1984) 0.77